ATG5 and hepatocellular carcinoma: Surprisingly, the combined treatment with DOX plus autophagy inhibition using the pharmacological inhibitor 3-MA or siRNA against ATG5 further increased apoptosis by 66% in the bulk HCC cells and 150% in the EpCAM+-CD133+ population of the HCC cells, respectively.